Low-Flow After TAVR Tied to Mortality Challenging to monitor but linked to outcome, PARTNER investigators say
Severe low-flow aortic stenosis after transcatheter aortic valve replacement (TAVR) is unlikely to normalize by 1 year and is linked to mortality, according to a secondary analysis of the PARTNER trial.